Atezolizumab Demonstrates "Excellent" Clinical Tolerability in Real-World NSCLC Study
Atezolizumab demonstrated clinical tolerability in a large, real-world cohort of older patients with non-small cell lung cancer (NSCLC), according to results published in the Japanese Jo...